Cargando…

Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model

BACKGROUND: Cognitive decline occurs frequently in Parkinson’s disease (PD), which greatly decreases the quality of life of patients. However, the mechanisms remain to be investigated. Neuroinflammation mediated by overactivated microglia is a common pathological feature in multiple neurological dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Dongdong, Li, Sheng, Hou, Liyan, Jing, Lu, Ruan, Zhengzheng, Peng, Bingjie, Zhang, Xiaomeng, Hong, Jau-Shyong, Zhao, Jie, Wang, Qingshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786472/ https://www.ncbi.nlm.nih.gov/pubmed/33402167 http://dx.doi.org/10.1186/s12974-020-02065-z

Ejemplares similares

Microglial Activation Mediates Noradrenergic Locus Coeruleus Neurodegeneration via Complement Receptor 3 in a Rotenone-Induced Parkinson’s Disease Mouse Model
por: Jing, Lu, et al.
Publicado: (2021)

Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson’s Disease Mouse Model
por: Ruan, Zhengzheng, et al.
Publicado: (2022)

Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase–NLRP3 inflammasome axis-dependent microglial activation
por: Hou, Liyan, et al.
Publicado: (2023)

Taurine protects dopaminergic neurons in a mouse Parkinson’s disease model through inhibition of microglial M1 polarization
por: Che, Yuning, et al.
Publicado: (2018)

Hypertension and Diagnosis of Parkinson’s Disease: A Meta-Analysis of Cohort Studies
por: Hou, Liyan, et al.
Publicado: (2018)

Comparison of the effect of rotenone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on inducing chronic Parkinson's disease in mouse models
por: Zhang, Jing, et al.
Publicado: (2022)

Rotenone, Paraquat, and Parkinson’s Disease
por: Tanner, Caroline M., et al.
Publicado: (2011)

The role of autophagy in Parkinson's disease: rotenone-based modeling
por: Xiong, Nian, et al.
Publicado: (2013)

NADPH oxidase-derived H(2)O(2) mediates the regulatory effects of microglia on astrogliosis in experimental models of Parkinson's disease
por: Hou, Liyan, et al.
Publicado: (2017)

Effects of chronic low dose rotenone treatment on human microglial cells
por: Shaikh, Shamim B, et al.
Publicado: (2009)

Opening of microglial K(ATP) channels inhibits rotenone-induced neuroinflammation
por: Zhou, Fang, et al.
Publicado: (2008)

Olfactory impairment is related to REM sleep deprivation in rotenone model of Parkinson's disease
por: Aurich, Mariana F., et al.
Publicado: (2017)

Curcumin protects against rotenone-induced Parkinson's disease in mice by inhibiting microglial NLRP3 inflammasome activation and alleviating mitochondrial dysfunction
por: Xu, Long, et al.
Publicado: (2023)

PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells
por: Broome, Sarah Thomas, et al.
Publicado: (2022)

Taste Impairments in a Parkinson’s Disease Model Featuring Intranasal Rotenone Administration in Mice
por: Yin, Dong Xu, et al.
Publicado: (2022)

Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats
por: Zaitone, Sawsan A., et al.
Publicado: (2012)

Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson's disease model
por: Hou, Liyan, et al.
Publicado: (2019)

The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson’s Disease
por: Thomas Broome, Sarah, et al.
Publicado: (2022)

Involvement of 5-lipoxygenase/cysteinyl leukotriene receptor 1 in rotenone- and MPP+-induced BV2 microglial activation
por: Wang, Yanfang, et al.
Publicado: (2012)

Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase
por: Jiang, Lulu, et al.
Publicado: (2016)

Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicity
por: Zhang, Dan, et al.
Publicado: (2011)

Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson's disease model rats★
por: Li, Chun, et al.
Publicado: (2012)

Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2011)

Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2009)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
por: Ojha, Shreesh, et al.
Publicado: (2015)

Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models
por: Zhang, Yu, et al.
Publicado: (2019)

Neuroprotective effects of Danshensu on rotenone-induced Parkinson’s disease models in vitro and in vivo
por: Wang, Tian, et al.
Publicado: (2020)

Excessive levels of nitric oxide in rat model of Parkinson’s disease induced by rotenone
por: XIONG, ZHONG-KUI, et al.
Publicado: (2015)

Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson’s disease model
por: Hou, Liyan, et al.
Publicado: (2020)

Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase
por: Qian, Li, et al.
Publicado: (2007)

Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice
por: Pan-Montojo, Francisco, et al.
Publicado: (2010)

Evidence of Oropharyngeal Dysfunction in Feeding in the Rat Rotenone Model of Parkinson's Disease
por: Gould, François D. H., et al.
Publicado: (2018)

Non-Reproducibility of Oral Rotenone as a Model for Parkinson’s Disease in Mice
por: Niederberger, Ellen, et al.
Publicado: (2022)

Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease
por: Gao, Hui-Ming, et al.
Publicado: (2011)

Adenosine A(2A) Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism
por: Fathalla, Ahmed M., et al.
Publicado: (2016)

Impaired Wnt signaling in dopamine containing neurons is associated with pathogenesis in a rotenone triggered Drosophila Parkinson’s disease model
por: Stephano, Flora, et al.
Publicado: (2018)

Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease
por: Ma, Chunmei, et al.
Publicado: (2023)

Cell Cycle Regulation of DNA Polymerase Beta in Rotenone-Based Parkinson's Disease Models
por: Wang, Hongcai, et al.
Publicado: (2014)

2,5-Hexanedione induces dopaminergic neurodegeneration through integrin α(M)β2/NADPH oxidase axis-mediated microglial activation
por: Zhang, Cong, et al.
Publicado: (2018)

Therapeutic effects of baicalein on rotenone-induced Parkinson’s disease through protecting mitochondrial function and biogenesis
por: Zhang, Xue, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_klffh8m047bnnbnuiiaovh7t7d